| Financial Year |
March 31 2023 |
| Monetary Funds |
204,966,813.01 |
| Held-for-trading Financial Assets |
222,388,700.00 |
| Notes Receivable |
1,987,460.77 |
| Accounts Receivable |
163,579,437.34 |
| Advances to Suppliers |
15,318,334.95 |
| Other Receivables |
1,805,187.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
228,436,009.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,974,639.03 |
| Other Current Assets |
7,330,429.91 |
| Total Current Assets |
1,187,556,415.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,131,925.72 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
218,100,772.46 |
| Under-construction Projects |
4,725,581.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,725,284.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,268,561.54 |
| Deferred Income Tax Assets |
7,931,519.34 |
| Other Non-Current Assets |
5,261,863.00 |
| Sub-Total of Non-Current Assets |
381,327,885.07 |
| Total Assets |
1,568,884,300.23 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
169,431,399.07 |
| Accounts Payable |
90,778,199.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,394,869.89 |
| Taxes Payable |
5,608,591.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,287,092.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,673,675.86 |
| Sub-Total of Current Liabilities |
368,509,795.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,206,387.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,206,387.40 |
| Total Liabilities |
369,716,183.22 |
| Paid-In Capital(Or Share Stock) |
214,716,125.00 |
| Capital Surplus |
136,940,177.05 |
| Surplus Reserve |
113,061,724.69 |
| LESS:Treasury Stock |
31,726,000.00 |
| Undistributed Profits |
758,961,043.34 |
| Minority Stockholder's Interest |
384,321.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,198,783,795.71 |
| Owner's Equity（Stockholder's Equity） |
1,199,168,117.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,568,884,300.23 |
